Selected article for: "Chikungunya virus and encephalitis virus"

Author: Miyssa I. Abdelmageed; Abdelrahman H. Abdelmoneim; Mujahed I. Mustafa; Nafisa M. Elfadol; Naseem S. Murshed; Shaza W. Shantier; Abdelrafie M. Makhawi
Title: Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach
  • Document date: 2020_2_11
  • ID: 6ojmmmuj_46
    Snippet: Designing of a novel vaccine is very crucial to defending the rapid endless of global burden of disease [56] [57] [58] [59] . In the last few decades, biotechnology has advanced rapidly; alongside with the understanding of immunology which assisted the rise of new approaches towards rational vaccines design [60] . Peptide-based vaccines are designed to elicit immunity particular pathogens by selectively stimulating antigen specific for B and T ce.....
    Document: Designing of a novel vaccine is very crucial to defending the rapid endless of global burden of disease [56] [57] [58] [59] . In the last few decades, biotechnology has advanced rapidly; alongside with the understanding of immunology which assisted the rise of new approaches towards rational vaccines design [60] . Peptide-based vaccines are designed to elicit immunity particular pathogens by selectively stimulating antigen specific for B and T cells [61] .Applying the advanced bioinformatics tools and databases, various peptide-based vaccines could be designed where the peptides act as ligands [62] [63] [64] . This approach has been used frequently in Saint Louis encephalitis virus [65] , dengue virus [66] , chikungunya virus [67] proposing promising peptides for designing vaccines.

    Search related documents:
    Co phrase search for related documents
    • chikungunya virus and encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • chikungunya virus and global burden: 1, 2, 3
    • chikungunya virus and new approach: 1
    • chikungunya virus and novel vaccine: 1, 2, 3, 4, 5, 6
    • dengue virus and disease global burden: 1, 2
    • dengue virus and encephalitis virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • dengue virus and global burden: 1, 2, 3, 4, 5, 6
    • dengue virus and new approach: 1, 2, 3
    • dengue virus and novel vaccine: 1, 2, 3, 4, 5, 6, 7, 8
    • disease global burden and global burden: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease global burden and novel vaccine: 1, 2, 3, 4
    • encephalitis virus and new approach: 1, 2, 3, 4, 5, 6, 7, 8
    • encephalitis virus and novel vaccine: 1, 2, 3, 4
    • global burden and new approach: 1, 2, 3
    • global burden and novel vaccine: 1, 2, 3, 4, 5, 6, 7
    • global burden and particular immunity: 1
    • new approach and novel vaccine: 1, 2, 3
    • new approach and particular immunity: 1
    • new approach and promise peptide: 1